Filing Details

Accession Number:
0001104659-25-011843
Form Type:
13G Filing
Publication Date:
2025-02-11 19:00:00
Filed By:
Thomas A. Satterfield, Jr.
Company:
Biocardia Inc. (OTCMKTS:BCDA)
Filing Date:
2025-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Thomas A. Satterfield, Jr. 0 388,147 8.2%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  * Based on 4,584,285 shares of common stock of the issuer outstanding as of November 5, 2024, as reported by the issuer in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024. This assumes the exercise of 156,982 warrants beneficially owned by the Reporting Person.


SCHEDULE 13G


 
Thomas A. Satterfield, Jr.
 
Signature:/s/ Thomas A. Satterfield, Jr.
Name/Title:Thomas A. Satterfield, Jr.
Date:02/12/2025